BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Johnston JL, Dhruva SS, Ross JS, Rathi VK. Clinical Evidence Supporting US Food and Drug Administration Clearance of Novel Therapeutic Devices via the De Novo Pathway Between 2011 and 2019. JAMA Intern Med 2020;180:1701-3. [PMID: 33044513 DOI: 10.1001/jamainternmed.2020.3214] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
Number Citing Articles
1 Dhruva SS, Zhang S, Chen J, Noseworthy PA, Doshi AA, Agboola KM, Herrin J, Jiang G, Yu Y, Cafri G, Collison Farr K, Ervin KR, Ross JS, Coplan PM, Drozda JP Jr. Safety and Effectiveness of a Catheter With Contact Force and 6-Hole Irrigation for Ablation of Persistent Atrial Fibrillation in Routine Clinical Practice. JAMA Netw Open 2022;5:e2227134. [PMID: 35976649 DOI: 10.1001/jamanetworkopen.2022.27134] [Reference Citation Analysis]
2 Dhruva SS, Darrow JJ, Kesselheim AS, Redberg RF. Experts' Views on FDA Regulatory Standards for Drug and High-Risk Medical Devices: Implications for Patient Care. J Gen Intern Med 2022. [PMID: 35138547 DOI: 10.1007/s11606-021-07316-0] [Reference Citation Analysis]
3 Kadakia KT, Beckman AL, Ross JS, Krumholz HM. Renewing the Call for Reforms to Medical Device Safety-The Case of Penumbra. JAMA Intern Med 2022;182:59-65. [PMID: 34842892 DOI: 10.1001/jamainternmed.2021.6626] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
4 Pogue BW, Rosenthal EL. Review of successful pathways for regulatory approvals in open-field fluorescence-guided surgery. J Biomed Opt 2021;26. [PMID: 33715318 DOI: 10.1117/1.JBO.26.3.030901] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
5 Gamstätter T. [The problem of medical overuse : Finding a definition and solutions]. Internist (Berl) 2021;62:343-53. [PMID: 33580822 DOI: 10.1007/s00108-021-00957-7] [Reference Citation Analysis]